drug summary · 2 NDC codes
REBIF REBIDOSE 44 ug/.5mL
INTERFERON BETA-1A
HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status BLA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.
Facts
Field definitions, types, and provenance rules are in the data dictionary.
| generic name | INTERFERON BETA-1A |
|---|---|
| active ingredients | INTERFERON BETA-1A |
| dosage form | INJECTION, SOLUTION |
| route | SUBCUTANEOUS |
| strength | 44 ug/.5mL |
| marketing status | BLA |
| DEA schedule | not reported |
| application number | BLA103780 |
| ATC code | not reported |
| RxCUI | not reported |
| manufacturer | EMD Serono, Inc. |
| product type | HUMAN PRESCRIPTION DRUG |
| pharmacologic class | Interferon beta [EPC]; Interferon-beta [CS] |
NDC codes
2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.
| NDC | Package description |
|---|---|
| 44087-3344 | — |
| 44087334401 | — |
Other INTERFERON BETA-1A products
5 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.
- REBIF REBIDOSEKIT · EMD Serono, Inc.
- RebifKIT · EMD Serono, Inc.
- REBIF 22 ug/.5mLINJECTION, SOLUTION · EMD Serono, Inc.
- REBIF REBIDOSE 22 ug/.5mLINJECTION, SOLUTION · EMD Serono, Inc.
- REBIF 44 ug/.5mLINJECTION, SOLUTION · EMD Serono, Inc.
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access to the full catalogue; credited toward the licence.